Sutro Biopharma Inc
NASDAQ:STRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sutro Biopharma Inc
NASDAQ:STRO
|
US |
|
M
|
MFC Asset Management PCL
SET:MFC
|
TH |
|
Affirm Holdings Inc
NASDAQ:AFRM
|
US |
Wall Street
Price Targets
STRO Price Targets Summary
Sutro Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
STRO
is 37.74 USD
with a low forecast of 8.08 USD and a high forecast of 105 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is STRO's stock price target?
Price Target
37.74
USD
According to Wall Street analysts, the average 1-year price target for
STRO
is 37.74 USD
with a low forecast of 8.08 USD and a high forecast of 105 USD.
What is Sutro Biopharma Inc's Revenue forecast?
Projected CAGR
-25%
For the last 8 years the
compound annual growth rate for
Sutro Biopharma Inc's revenue is
9%.
The projected
CAGR
for the next 3 years is
-25%.
